Christopher B. Jones

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Clark D Russell, Cameron J Fairfield, Thomas M Drake et al. · The Lancet Microbe · 2021 · 334 citations · Full text

Pharmacy, Infectious Disease Control, Infectious Diseases +17

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K. Siggins et al. · Science Immunology · 2021 · 259 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Chloë I. Bloom, Thomas M Drake, Annemarie B Docherty et al. · The Lancet Respiratory Medicine · 2021 · 196 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Effect of Exercise Training on Estimated GFR, Vascular Health, and Cardiorespiratory Fitness in Patients With CKD: A Pilot Randomized Controlled Trial

Sharlene A. Greenwood, Pelagia Koufaki, Thomas H. Mercer et al. · American Journal of Kidney Diseases · 2014 · 191 citations

Education, Physiology, Exercise Physiology +16

THE POTASSIUM-SPARING AND NATRIURETIC ACTIVITY OF N-AMIDINO-3,5-DIAMINO-6-CHLOROPYRAZINECAR-BOXAMIDE HYDROCHLORIDE DIHYDRATE (AMILORIDE HYDROCHLORIDE)

John E. Baer, Christopher B. Jones, S. Spitzer et al. · Journal of Pharmacology and Experimental Therapeutics · 1967 · 160 citations

Medicine, Pharmacology, Excretion +6